Ganga Pharmaceuticals Ltd.

25.69 +1.22 ▲5.0%

26 February 2024, 01:44:00 PM
Volume: 8,000

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ayurvedganga.com
Market Cap 12.42 Cr.
Enterprise Value(EV) 13.57 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.08 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 316.08 Trailing Twelve Months Ending 2023-03
Industry PE 41.88 Trailing Twelve Months Ending 2023-03
Book Value / Share 12.87 Trailing Twelve Months Ending 2023-03
Price to Book Value 2.00 Calculated using Price: 25.69
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.48 Cr. 4,836,500 Shares
FaceValue 10
About Ganga Pharmaceuticals Ltd.
The company is a producer of quality bulk ayurvedic medicines in Mumbai. Apart from manufacturing, the company is also into marketing, distribution of Bulk Ayurvedic Medicines. Its product includes Ampachan Vati; Khadira Vati; Nirmalaya churna etc. Its products are available in liquid dosage form and solid dosage forms.

Ganga Pharmaceuticals Ltd. Delivery

Delivered Qty
Traded Qty

Ganga Pharmaceuticals Ltd. Performance

1 Day
+4.99%
1 Week
+4.99%
1 Month
-5.20%
3 Month
+116.25%
6 Month
+139.20%
1 Year
+84.42%
2 Year
+95.36%
5 Year
+328.17%
10 Year

Ganga Pharmaceuticals Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 1.28 1.36 1.57 1.91 3.7 3.59 0.38 0.7 0.72
Return on Capital Employed (%) 8.03 6.88 6.15 5.83 7.26 7.18 3.36 3.41 3.38
Return on Assets (%) 0.64 0.77 0.99 1.19 2.34 2.46 0.27 0.48 0.49

Ganga Pharmaceuticals Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 3 5 5 5 5 5 5 5 5 5
Non Curr. Liab. 2 1 1 1 1 1 1 1 1 1
Curr. Liab. 1 1 2 2 2 2 2 2 2 2
Minority Int.
Equity & Liab. 5 7 8 8 8 8 8 8 8 8
Non Curr. Assets 3 3 3 4 3 3 3 3 3 2
Curr. Assets 2 5 4 5 4 4 5 5 5 6
Misc. Exp. not W/O 0
Total Assets 5 7 8 8 8 8 8 8 8 8

Ganga Pharmaceuticals Ltd. Profit and Loss

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 3 3 3 3 3 3 3 2 2 3
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 3 3 3 3 3 4 3 3 3 3
Total Expenditure -2 -2 -2 -3 -3 -3 -3 -2 -2 -3
PBIDT 0 0 0 0 0 1 1 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 0 0 0 0 0 0

Ganga Pharmaceuticals Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -1 0 0 0 0 0 0 0
Cash Fr. Inv. 0 0 -1 1 0 0 0 0 0 0
Cash Fr. Finan. 0 0 2 0 0 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 1 0 0 0 0 0 0

Ganga Pharmaceuticals Ltd. Shareholding Pattern

9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2023-03 (%) 2023-09 (%) 2023-12 (%)
Promoter 66.71 66.71 66.71 66.71 66.71 66.71 66.71 66.71 56.02
Public 33.29 33.29 33.29 33.29 33.29 33.29 33.29 33.29 43.98
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Ganga Pharmaceuticals Ltd. Announcements

Wed, 07 Feb 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Plutus Capital Management LLP
Wed, 07 Feb 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Lenus Finvest Pvt Ltd
Wed, 07 Feb 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bhavesh Dhirajilal Tanna

Ganga Pharmaceuticals Ltd. Technical Scans

Fri, 16 Feb 2024
Opening at High Opening at High
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month

Ganga Pharmaceuticals Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 374,572.18 1,554.65 -0.4%
Cipla Ltd. 118,375.92 1,469.30 +0.2%
Dr. Reddy's Laboratories Ltd. 107,511.08 6,424.45 -0.3%
Apollo Hospitals Enterprise Ltd. 97,345.81 6,616.65 -2.3%
Divi's Laboratories Ltd. 96,748.70 3,567.80 -2.2%
Zydus Lifesciences Ltd. 93,335.34 940.70 +1.9%
Torrent Pharmaceuticals Ltd. 88,913.00 2,624.90 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.06 1,554.65 -0.4%
Cipla Ltd. Consolidated 2023-12 31.92 1,469.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.56 6,424.45 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.33 6,616.65 -2.3%
Divi's Laboratories Ltd. Consolidated 2023-12 69.96 3,567.80 -2.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.39 940.70 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.51 2,624.90 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.00 1,554.65 -0.4%
Cipla Ltd. Consolidated 2023-12 4.57 1,469.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,424.45 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,616.65 -2.3%
Divi's Laboratories Ltd. Consolidated 2023-12 7.42 3,567.80 -2.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.80 940.70 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.43 2,624.90 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,554.65 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,469.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,424.45 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,616.65 -2.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,567.80 -2.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 940.70 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,624.90 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,554.65 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,469.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.45 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,616.65 -2.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,567.80 -2.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 940.70 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,624.90 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,554.65 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,469.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.45 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,616.65 -2.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,567.80 -2.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 940.70 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,624.90 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,554.65 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,469.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,424.45 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,616.65 -2.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,567.80 -2.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 940.70 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,624.90 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,554.65 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,469.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,424.45 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,616.65 -2.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,567.80 -2.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 940.70 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,624.90 -0.1%

Ganga Pharmaceuticals Ltd. FAQ's

What is Ganga Pharma. share price?

Can I buy Ganga Pharma. shares now?

What is the Market Cap of Ganga Pharma.?

What are the key metrics to analyse Ganga Pharma.?

What is the 52 Week High and Low of Ganga Pharma.?

What is the trend of Ganga Pharma. share price?